Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zentalis Pharmaceuticals (ZNTL) Deferred Taxes (2022 - 2023)

Historic Deferred Taxes for Zentalis Pharmaceuticals (ZNTL) over the last 2 years, with Q2 2023 value amounting to -$756000.0.

  • Zentalis Pharmaceuticals' Deferred Taxes fell 112162.16% to -$756000.0 in Q2 2023 from the same period last year, while for Mar 2024 it was -$756000.0, marking a year-over-year increase of 454.55%. This contributed to the annual value of -$853000.0 for FY2023, which is 1092.33% down from last year.
  • Latest data reveals that Zentalis Pharmaceuticals reported Deferred Taxes of -$756000.0 as of Q2 2023, which was down 112162.16% from -$97000.0 recorded in Q1 2023.
  • Over the past 5 years, Zentalis Pharmaceuticals' Deferred Taxes peaked at $74000.0 during Q2 2022, and registered a low of -$769000.0 during Q4 2022.